What is Halozyme Therapeutics's investment purchases?

Halozyme Therapeutics (HALO) reported investment purchases of $8.85M in Q1 2026.

How has Halozyme Therapeutics's investment purchases changed year-over-year?

Halozyme Therapeutics's investment purchases decreased by 93.7% year-over-year, from $139.64M to $8.85M.

What is the long-term trend for Halozyme Therapeutics's investment purchases?

Over 4 years (2021 to 2025), Halozyme Therapeutics's investment purchases has grown at a -21.5% compound annual growth rate (CAGR), from $652.52M to $247.36M.

What does investment purchases mean?

Cash spent purchasing investment securities across all categories.

Halozyme Therapeutics HALO Investment Purchases

Investment Purchases at other companies

BridgeBio PharmaBBIO

$52.67M—

Arrowhead ResearchARWR

$924.64M+43.5%

United TherapeuticsUTHR

$701.7M+1.4%

Krystal Biotech, Inc.KRYS

$160.03M+16.1%

Ionis PharmaceuticalsIONS

$192.76M-38.0%

Spyre Therapeutics, Inc.SYRE

$81.17M+13.6%

Other financials

Income statement

See full

Revenue$376.7M+42.2%

Gross profit$297.5M+37.4%

Operating income$184.5M+30.4%

Net income$150.0M+27.1%

EPS (diluted)$1.22+31.2%

Balance sheet

See full

Cash & equivalents$312.0M+76.9%

Total debt$2.2B+41.7%

Total equity$219.6M-54.5%

Total assets$2.7B+21.7%

Cash flow

See full

Operating cash flow$180.1M+16.8%

CapEx$3.7M+294%

Free cash flow$176.3M+15.0%

Valuation

See full

Market cap$8.13B-2.9%

Enterprise value$10B+3.0%

P/E13.4×-3.8×

P/S5.4×-2.3×

Profitability

See full

Gross margin82.8%-0.7pp

Operating margin59.3%+9.0pp

Net margin47.9%+6.5pp

FCF margin44.3%-1.5pp

Returns & leverage

See full

Return on equity124.5%+12.7pp

Debt / equity9.9×+6.7×

Current ratio2.8×-5.6×

Where this comes from

Reported directly by Halozyme Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: Halozyme Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Halozyme Therapeutics's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Halozyme Therapeutics's investment purchases?: Halozyme Therapeutics (HALO) reported investment purchases of $8.85M in Q1 2026.
How has Halozyme Therapeutics's investment purchases changed year-over-year?: Halozyme Therapeutics's investment purchases decreased by 93.7% year-over-year, from $139.64M to $8.85M.
What is the long-term trend for Halozyme Therapeutics's investment purchases?: Over 4 years (2021 to 2025), Halozyme Therapeutics's investment purchases has grown at a -21.5% compound annual growth rate (CAGR), from $652.52M to $247.36M.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.